| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8336 |
| Human Intestinal Absorption | HIA+ | 0.9956 |
| Caco-2 Permeability | Caco2+ | 0.8414 |
| P-glycoprotein Substrate | Non-substrate | 0.5106 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9146 |
| Non-inhibitor | 0.9264 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7802 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8282 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7936 |
| CYP450 2D6 Substrate | Non-substrate | 0.8637 |
| CYP450 3A4 Substrate | Non-substrate | 0.5739 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6807 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8653 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8558 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.5913 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8427 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8392 |
| Non-inhibitor | 0.7501 |
| AMES Toxicity | Non AMES toxic | 0.9715 |
| Carcinogens | Non-carcinogens | 0.8435 |
| Fish Toxicity | High FHMT | 0.9533 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9957 |
| Honey Bee Toxicity | High HBT | 0.7278 |
| Biodegradation | Ready biodegradable | 0.8176 |
| Acute Oral Toxicity | III | 0.7446 |
| Carcinogenicity (Three-class) | Non-required | 0.6495 |